TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
尤素夫·A.
1 个月前
安妮塔· G.
2 个月前
阿里·H.
1天前
阿卜杜拉·B.
3 周前